Vitamin C and Charcot–Marie–Tooth 1A: Pharmacokinetic considerations

por Visioli, F., Reilly, M.M., Rimoldi, M., Solari, A., Pareyson, D.
Publicado 2013

Postural stabilization and balance assessment in Charcot–Marie–Tooth 1A subjects

por Lencioni, T., Rabuffetti, M., Piscosquito, G., Pareyson, D., Aiello, A., Di Sipio, E., Padua, L., Stra, F., Ferrarin, M.
Publicado 2014

Treadmill training in patients affected by Charcot–Marie–Tooth neuropathy: results of a multicenter, prospective, randomized, single‐blind, controlled study

por Mori, L., Signori, A., Prada, V., Pareyson, D., Piscosquito, G., Padua, L., Pazzaglia, C., Fabrizi, G. M., Picelli, A., Schenone, A.
Publicado 2019

Reliability of instrumented movement analysis as outcome measure in Charcot–Marie–Tooth disease: Results from a multitask locomotor protocol

por Ferrarin, M., Bovi, G., Rabuffetti, M., Mazzoleni, P., Montesano, A., Moroni, I., Pagliano, E., Marchi, A., Marchesi, C., Beghi, E., Pareyson, D.
Publicado 2011

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus

por Grandis, M., Obici, L., Luigetti, M., Briani, C., Benedicenti, F., Bisogni, G., Canepa, M., Cappelli, F., Danesino, C., Fabrizi, G. M., Fenu, S., Ferrandes, G., Gemelli, C., Manganelli, F., Mazzeo, A., Melchiorri, L., Perfetto, F., Pradotto, L. G., Rimessi, P., Tini, G., Tozza, S., Trevisan, L., Pareyson, D., Mandich, P.
Publicado 2020

CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis

por Fridman, V, Bundy, B, Reilly, M M, Pareyson, D, Bacon, C, Burns, J, Day, J, Feely, S, Finkel, R S, Grider, T, Kirk, C A, Herrmann, D N, Laurá, M, Li, J, Lloyd, T, Sumner, C J, Muntoni, F, Piscosquito, G, Ramchandren, S, Shy, R, Siskind, C E, Yum, S W, Moroni, I, Pagliano, E, Zuchner, S, Scherer, S S, Shy, M E
Publicado 2015